科兴生物 (SVA.O)

+ 收藏

资产负债表(科兴生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
截止日期 2024-06-302023-12-312023-06-302022-12-312022-06-30
报表类型 合并报表合并报表合并报表合并报表合并报表
报表年结日 12311231123112311231
原始币种 美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 1,072,350,000.001,270,131,000.001,643,026,000.004,278,124,000.006,857,905,000.00
 受限制存款及现金流动(元) 2,779,000.005,166,000.003,734,000.008,253,000.009,189,000.00
 应收账款及票据(元) 370,168,000.00440,019,000.00425,245,000.00537,118,000.00969,561,000.00
 应收关联方款项(元) 23,847,000.00----
 预付款项及其他应收款流动(元) 12,724,000.0011,621,000.0013,312,000.0015,242,000.0023,328,000.00
 存货(元) 153,524,000.00139,874,000.00182,735,000.00180,719,000.00266,864,000.00
 可收回本期税项(元) 10,703,000.0010,703,000.0075,195,000.0072,371,000.00-
 短期投资(元) 9,502,185,000.009,953,042,000.009,425,778,000.007,034,569,000.004,988,240,000.00
 流动资产合计(元) 11,148,280,000.0011,830,556,000.0011,769,025,000.0012,126,396,000.0013,115,087,000.00
非流动资产:
 物业、厂房及设备(元) 934,614,000.00979,617,000.001,058,962,000.00993,781,000.00949,422,000.00
 无形资产(元) 7,844,000.008,520,000.008,753,000.009,699,000.001,315,000.00
 预付款项及其他长期应收款非流动(元) 67,278,000.0072,336,000.0081,833,000.00190,750,000.00174,677,000.00
 递延所得税资产非流动(元) 32,798,000.0029,790,000.0098,688,000.0071,118,000.0064,821,000.00
 长期投资(元) 681,345,000.00684,285,000.00657,767,000.00661,440,000.00697,115,000.00
 非流动资产其他项目(元) 24,778,000.0052,870,000.0049,982,000.0061,384,000.0063,347,000.00
 非流动资产合计(元) 1,748,657,000.001,827,418,000.001,955,985,000.001,988,172,000.001,950,697,000.00
总资产(元) 12,896,937,000.0013,657,974,000.0013,725,010,000.0014,114,568,000.0015,065,784,000.00
流动负债:
 短期债务及长期负债本期部分(元) 179,349,000.0076,089,000.00205,277,000.004,651,000.001,605,000.00
 融资租赁负债流动(元) 2,451,000.005,806,000.005,990,000.005,993,000.006,367,000.00
 应付账款及票据(元) 641,579,000.00973,949,000.00819,530,000.00905,923,000.00334,294,000.00
 应付税项流动(元) 28,720,000.0041,258,000.00--158,540,000.00
 其他应付款及应计费用(元) 119,374,000.0029,089,000.00139,547,000.00141,993,000.0020,083,000.00
 递延收入流动(元) 6,978,000.0021,713,000.0019,285,000.0033,075,000.0043,972,000.00
 流动负债合计(元) 978,451,000.001,147,904,000.001,189,629,000.001,091,635,000.00564,861,000.00
非流动负债:
 长期债务(元) 130,320,000.00177,817,000.0010,989,000.0011,513,000.0016,629,000.00
 融资租赁负债非流动(元) 12,388,000.0039,271,000.0040,929,000.0052,516,000.0057,118,000.00
 递延收入非流动(元) 6,179,000.006,065,000.006,548,000.004,477,000.007,265,000.00
 递延所得税负债非流动(元) 262,174,000.00263,711,000.00239,029,000.00241,526,000.00325,917,000.00
 非流动负债其他项目(元) 429,000.00439,000.00630,000.00240,000.00137,000.00
 非流动负债合计(元) 411,490,000.00487,303,000.00298,125,000.00310,272,000.00407,066,000.00
总负债(元) 1,389,941,000.001,635,207,000.001,487,754,000.001,401,907,000.00971,927,000.00
股东权益:
 普通股(元) 100,000.00100,000.00100,000.00100,000.00100,000.00
 优先股(元) 15,000.0015,000.0015,000.0015,000.0015,000.00
 股本溢价(元) 541,258,000.00541,258,000.00541,258,000.00540,582,000.00547,691,000.00
 留存收益(元) 7,107,644,000.007,118,516,000.007,239,947,000.007,225,987,000.007,623,373,000.00
 其他储备(元) 1,539,584,000.001,539,584,000.001,538,013,000.001,538,013,000.001,514,297,000.00
 累计其他全面收益(元) -539,415,000.00-490,055,000.00-654,462,000.00-383,276,000.00-217,469,000.00
 归属于母公司股东权益(元) 8,649,186,000.008,709,418,000.008,664,871,000.008,921,421,000.009,468,007,000.00
 少数股东权益(元) 2,857,810,000.003,313,349,000.003,572,385,000.003,791,240,000.004,625,850,000.00
 股东权益合计(元) 11,506,996,000.0012,022,767,000.0012,237,256,000.0012,712,661,000.0014,093,857,000.00
负债及股东权益合计(元) 12,896,937,000.0013,657,974,000.0013,725,010,000.0014,114,568,000.0015,065,784,000.00
公告日期 2024-08-162024-04-292023-08-152023-05-012022-12-29
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院